8 results on '"Enders, M."'
Search Results
2. Reply to "Better method for evaluating a new laboratory test for syphilis".
- Author
-
Enders M, Gleich M, Mühlbacher A, Sakuldamrongpanich T, Turhan A, Sertöz R, Semprini S, and Sambri V
- Subjects
- Humans, Antibodies, Bacterial blood, Diagnostic Tests, Routine methods, Syphilis diagnosis, Treponema pallidum immunology
- Published
- 2015
- Full Text
- View/download PDF
3. Performance evaluation of the Elecsys syphilis assay for the detection of total antibodies to Treponema pallidum.
- Author
-
Enders M, Hunjet A, Gleich M, Imdahl R, Mühlbacher A, Schennach H, Chaiwong K, Sakuldamrongpanich T, Turhan A, Sertöz R, Wolf E, Mayer W, Tao C, Wang LL, Semprini S, and Sambri V
- Subjects
- Humans, Immunoassay methods, Reagent Kits, Diagnostic, Sensitivity and Specificity, Syphilis immunology, Antibodies, Bacterial blood, Diagnostic Tests, Routine methods, Syphilis diagnosis, Treponema pallidum immunology
- Abstract
Syphilis is a health problem of increasing incidence in recent years that may have severe complications if not diagnosed and treated at an early stage. There are many diagnostic tests available for syphilis, but there is no gold standard, and diagnosis therefore usually relies upon a combination of tests. In this multicenter study, we evaluated the treponemal Elecsys syphilis assay for use in the diagnosis of syphilis in routine samples, i.e., when syphilis is suspected or during antenatal or blood donation screening. The sensitivity and specificity of the Elecsys syphilis assay were compared head to head with those of other treponemal assays used in routine clinical practice and were assessed in potentially cross-reactive samples from patients with Epstein-Barr virus, HIV, and Lyme disease. In a total of 8,063 syphilis-negative samples collected from routine diagnostic requests and blood donations, the Elecsys syphilis assay had a specificity of 99.88%. In 928 samples previously identified as syphilis positive, the sensitivity was 99.57 to 100% (the result is presented as a range depending on whether four initially indeterminate samples are included in the assessment). The specificity of the Elecsys syphilis assay in patients with other infections was 100%; no false-positive samples were identified., (Copyright © 2015, American Society for Microbiology. All Rights Reserved.)
- Published
- 2015
- Full Text
- View/download PDF
4. [Syphilis].
- Author
-
Enders M, Regnath T, Tewald F, and Hassler D
- Subjects
- Germany epidemiology, Humans, Incidence, Sentinel Surveillance, Treponema pallidum classification, Syphilis epidemiology, Syphilis pathology, Syphilis prevention & control, Syphilis transmission, Treponema pallidum isolation & purification
- Published
- 2007
5. [Congenital syphilis despite prenatal screening? An evaluation of 14 cases].
- Author
-
Enders M, Knaub I, Gohl M, Pieper I, Bialek C, and Hagedorn HJ
- Subjects
- Adolescent, Adult, Female, Humans, Pregnancy, Syphilis, Congenital prevention & control, Pregnancy Complications diagnosis, Prenatal Diagnosis methods, Syphilis complications, Syphilis diagnosis, Syphilis, Congenital diagnosis, Syphilis, Congenital etiology
- Abstract
Background: Congenital syphilis (CS) can be effectively avoided by adequate treatment of the mother during pregnancy. Nevertheless, in recent years, the Robert Koch Institute has reported 6-8 of CS cases per year. The aim of this study was to investigate cases of CS with regard to obstetrical history and results of maternal syphilis serology during pregnancy and postpartum., Patients and Methods: Between 1997 and 2001, a total of 14 cases of CS were diagnosed after birth in the Stuttgart laboratory. Information on clinical and serological data obtained during prenatal care and at birth had been provided by the treating gynaecologists and paediatricians. Furthermore, serum samples from 11 of the 14 mothers were investigated at the Stuttgart laboratory after birth and also retrospectively at the Herford laboratory., Results: All mothers presented without clinical signs of syphilis. Delayed prenatal care was observed in 6 out of 14 cases. Eleven of the 14 mothers had a positive treponemal screening test. Treatment was initiated only in two of them. During pregnancy treponemal IgM and cardiolipin antibodies were detected in none of 9 and in 5 of 8 sera of untreated mothers, respectively. In contrast, maternal serum samples investigated after birth were all positive for cardiolipin antibodies and 7 of 10 serum samples were positive for TP IgM antibodies., Conclusions: Delayed or absent prenatal care and misinterpretation of syphilis serology (or laboratory failures) in the presence of latent syphilis are mostly responsible for the inadequate management of syphilis during pregnancy and thus the occurrence of CS.
- Published
- 2006
- Full Text
- View/download PDF
6. [Syphilis in pregnancy].
- Author
-
Enders M and Hagedorn HJ
- Subjects
- AIDS-Related Opportunistic Infections drug therapy, AIDS-Related Opportunistic Infections epidemiology, Cross-Sectional Studies, Female, Germany epidemiology, Humans, Incidence, Infant, Newborn, Penicillins adverse effects, Penicillins therapeutic use, Pregnancy, Pregnancy Complications, Infectious drug therapy, Pregnancy Complications, Infectious epidemiology, Syphilis drug therapy, Syphilis epidemiology, AIDS-Related Opportunistic Infections diagnosis, Pregnancy Complications, Infectious diagnosis, Syphilis diagnosis
- Abstract
Syphilis, a sexually transmitted infection, has a major impact on the disease burden worldwide. Globally, an estimated 12 million new cases of sexually acquired syphilis occurred in 1997. Developing countries in Africa, Southeast Asia and regions of the former Soviet Union are mainly affected. With rising numbers of human immunodeficiency virus-infected pregnant women and an increase in gonorrhoea in some areas, the incidence of syphilis is expected to increase again. As a consequence of migration from Eastern bloc countries to Europe after the breakdown of the former Soviet Union, the resurgence of syphilis will also affect Germany. Therefore, we present the clinical picture of syphilis as well as review the current recommendations of the German STD Society, the Centers of Disease Control (CDC), USA, and the Clinical Effectiveness Group (CEG), England, for diagnosis and treatment of syphilis with special emphasis on pregnancy. Considering the current epidemiological situation, physicians should include syphilis in their differential diagnosis. Although recommended therapy regimens differ, penicillin is the treatment of choice. Pregnant patients who are allergic to penicillin should be desensitized and treated with penicillin. Early recognition and timely treatment of syphilis are essential to prevent or treat potentially fatal fetal infection.
- Published
- 2002
- Full Text
- View/download PDF
7. Performance Evaluation of the Elecsys Syphilis Assay for the Detection of Total Antibodies to Treponema pallidum
- Author
-
Kriangsak Chaiwong, Andrea Hunjet, Wolfgang Mayer, Ajda Turhan, Vittorio Sambri, Rüçhan Sertöz, Martin Enders, Harald Schennach, Annelies Mühlbacher, Eva Wolf, Lan Lan Wang, Simona Semprini, Tasanee Sakuldamrongpanich, Chuanmin Tao, Michael Gleich, Roland Imdahl, Ege Üniversitesi, Enders, M, Hunjet, A, Gleich, M, Imdahl, R, Mühlbacher, A, Schennach, H, Chaiwong, K, Sakuldamrongpanich, T, Turhan, A, Sertöz, R, Wolf, E, Mayer, W, Tao, C, Wang, Ll, Semprini, S, and Sambri, V.
- Subjects
Syphilis, Laboratory Diagnosis, Chemiluminescence assay ,Microbiology (medical) ,medicine.medical_specialty ,Clinical Biochemistry ,Immunology ,Sensitivity and Specificity ,Lyme disease ,Diagnostic Laboratory Immunology ,Internal medicine ,medicine ,Humans ,Immunology and Allergy ,Syphilis ,Treponema pallidum ,Letters to the Editor ,Immunoassay ,Treponema ,medicine.diagnostic_test ,biology ,Diagnostic Tests, Routine ,business.industry ,Incidence (epidemiology) ,Gold standard (test) ,medicine.disease ,biology.organism_classification ,Antibodies, Bacterial ,Multicenter study ,biology.protein ,Reagent Kits, Diagnostic ,Antibody ,business - Abstract
WOS: 000348771800003, PubMed ID: 25355799, Syphilis is a health problem of increasing incidence in recent years that may have severe complications if not diagnosed and treated at an early stage. There are many diagnostic tests available for syphilis, but there is no gold standard, and diagnosis therefore usually relies upon a combination of tests. In this multicenter study, we evaluated the treponemal Elecsys syphilis assay for use in the diagnosis of syphilis in routine samples, i.e., when syphilis is suspected or during antenatal or blood donation screening. The sensitivity and specificity of the Elecsys syphilis assay were compared head to head with those of other treponemal assays used in routine clinical practice and were assessed in potentially cross-reactive samples from patients with Epstein-Barr virus, HIV, and Lyme disease. In a total of 8,063 syphilis-negative samples collected from routine diagnostic requests and blood donations, the Elecsys syphilis assay had a specificity of 99.88%. In 928 samples previously identified as syphilis positive, the sensitivity was 99.57 to 100% (the result is presented as a range depending on whether four initially indeterminate samples are included in the assessment). The specificity of the Elecsys syphilis assay in patients with other infections was 100%; no false-positive samples were identified., Roche Diagnostics GmbH (Penzberg, Germany); Roche Diagnostics GmbH; Novartis Diagnostics; Roche Diagnostics; DiaSorin; bioMerieux, Funding for the study was provided by Roche Diagnostics GmbH (Penzberg, Germany). Rebecca Gardner (Elements Communications Ltd., Westerham, United Kingdom) provided medical writing assistance supported by Roche Diagnostics GmbH.; V. Sambri declares speaker's fees from Novartis Diagnostics and Roche Diagnostics. V. Sambri has received research funding from Roche Diagnostics, Novartis Diagnostics, DiaSorin, and bioMerieux. H. Schennach received travel fees for attendance at an advisory board for Roche Diagnostics.
- Published
- 2015
8. Reply to 'Better Method for Evaluating a New Laboratory Test for Syphilis'
- Author
-
Ajda Turhan, Michael Gleich, Martin Enders, Tasanee Sakuldamrongpanich, Annelies Mühlbacher, Vittorio Sambri, Rüçhan Sertöz, Simona Semprini, Enders, M, Gleich, M, Mühlbacher, A, Sakuldamrongpanich, T, Turhan, A, Sertöz, R, Semprini, S, and Sambri, V.
- Subjects
Microbiology (medical) ,Syphilis, laboratory diagnosis, Chemiluminescnce assay ,Computer science ,business.industry ,Clinical Biochemistry ,Immunology ,Zhàng ,bacterial infections and mycoses ,urologic and male genital diseases ,medicine.disease ,Laboratory test ,medicine ,Immunology and Allergy ,Syphilis ,Artificial intelligence ,business - Abstract
This article is in response to the [correspondence][1] from Zhang et al. ([1][2]) relating to the methodology used in the study by Enders et al. ([2][3]). The correspondence from Zhang et al. does not present a better method. Instead, it criticizes a well-known and widely used method for evaluating
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.